Activation of FGF receptors by mutations in the transmembrane domain (original) (raw)

Oncogene volume 14, pages 1397–1406 (1997)Cite this article

Abstract

Signaling through FGF receptors, which constitute a family of membrane-spanning tyrosine kinases, can stimulate cell proliferation, induce or inhibit cell differentiation and plays an important role in development. Recently, mutations in FGF receptors have been shown to be associated with a number of genetically dominant human skeletal disorders. A remarkably conserved mutation (Gly 380→Arg) in the transmembrane region of FGFR-3 has been shown to be responsible for achondroplasia (ACH) but it was not clear whether such mutations result in loss of receptor function or constitutive activation. We have therefore made mutations in the transmembrane regions of murine FGFR-2 and FGFR-3 and studied their effect on receptor activity. We show here that the ACH mutation in FGFR-3 as well as two similar mutations in FGFR-2 result in constitutive activation of these receptors. This is manifested in their ability to become autophosphorylated in the absence of ligand in L6 cells, transforming activity on NIH3T3 fibroblasts, and the ability to inhibit myogenic differentiation in the absence of growth factor. Thus the transmembrane region of FGFR-2 and FGFR-3 plays a regulatory role in receptor function and the ACH mutation produces a dominant oversignaling receptor which is no longer regulated by FGF binding. These findings also support the newly identified role of FGF signaling as a negative regulator of bone growth.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 50 print issues and online access

$259.00 per year

only $5.18 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Microbiology and Kaplan Cancer Center, New York University School of Medicine, New York, 10016, NY, USA
    Yan Li, Karen Mangasarian, Alka Mansukhani & Claudio Basilico

Authors

  1. Yan Li
    You can also search for this author inPubMed Google Scholar
  2. Karen Mangasarian
    You can also search for this author inPubMed Google Scholar
  3. Alka Mansukhani
    You can also search for this author inPubMed Google Scholar
  4. Claudio Basilico
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Li, Y., Mangasarian, K., Mansukhani, A. et al. Activation of FGF receptors by mutations in the transmembrane domain.Oncogene 14, 1397–1406 (1997). https://doi.org/10.1038/sj.onc.1200983

Download citation

Keywords

This article is cited by